PD Dr. Simone Bertz



Organisationseinheit


Pathologisches Institut


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 4 Go to next page Go to last page

Stubendorff, B., Wilhelm, K., Posselt, K., Catto, J., Hartmann, A., Bertz, S.,... Junker, K. (2019). A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer. Journal of Cancer Research and Clinical Oncology, 145(4), 811-820. https://dx.doi.org/10.1007/s00432-018-02829-4
Merten, R., Ott, O., Haderlein, M., Bertz, S., Hartmann, A., Wullich, B.,... Fietkau, R. (2019). Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2). Oncologist. https://dx.doi.org/10.1634/theoncologist.2018-0280
Stoehr, R., Wendler, O.D., Giedl, J., Gaisa, N.T., Richter, G., Campean, V.,... Hartmann, A. (2019). No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis. Pathobiology, 86(2-3), 145-151. https://dx.doi.org/10.1159/000495251
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Pfannstiel, C., Strissel, P., Chiappinelli, K.B., Sikic, D., Wach, S., Wirtz, R.M.,... Eckstein, M. (2019). The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes. Cancer Immunology Research, 7(6), 923-938. https://dx.doi.org/10.1158/2326-6066.CIR-18-0758
Worst, T.S., Weis, C.-A., Stoehr, R., Bertz, S., Eckstein, M., Otto, W.,... Erben, P. (2018). CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific Reports, 8(1). https://dx.doi.org/10.1038/s41598-018-32569-x
Eckstein, M., Agaimy, A., Woenckhaus, J., Winter, A., Bittmann, I., Janzen, J.,... Hartmann, A. (2018). DICER1 mutation-positive Giant Botryoid Fibroepithelial polyp of the urinary bladder mimicking embryonal rhabdomyosarcoma. Human Pathology. https://dx.doi.org/10.1016/j.humpath.2018.05.015
Breyer, J., Wirtz, R.M., Erben, P., Worst, T.S., Stoehr, R., Eckstein, M.,... Otto, W. (2018). High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. Clinical Genitourinary Cancer. https://dx.doi.org/10.1016/j.clgc.2018.01.009
Otto, W., Van Rhijn, B.W.G., Breyer, J., Bertz, S., Eckstein, M., Mayr, R.,... Hartmann, A. (2018). Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naïve stage T1 high-grade urothelial bladder cancer. International Journal of Urology, 25(5), 442-449. https://dx.doi.org/10.1111/iju.13532
Van De Putte, E.E.F., Otto, W., Hartmann, A., Bertz, S., Mayr, R., Bruendl, J.,... Van Rhijn, B.W.G. (2018). Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2018.05.007

Zuletzt aktualisiert 2017-15-10 um 02:01